What they were paid
Alkermes Director Compensation Table · all 3 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $116,319 | $187,515 | $187,499 | $0 | $491,333 |
| FY2024 | $108,170 | $187,504 | $187,490 | $0 | $483,164 |
| FY2023 | $107,000 | $187,510 | $187,530 | $0 | $482,040 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Alkermes plc. DEF 14A filed April 6, 2026, accession 0001193125-26-143977, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Alkermes pays directors a $74,000 cash retainer and $375,000 in RSUs and Stock Options (50/50 split).
Committees
FY2025 · as the proxy prints themCompensation · Nominating/Governance · Financial Operating (Chair)
The rest of the Alkermes board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Cato T. Laurencin, M.D., Ph.D | Independent Director | $461,014 |
| Christopher I. Wright, M.D., Ph.D | Independent Director | $477,843 |
| Frank Anders Wilson | Lead Independent Director | $527,234 |
| Nancy L. Snyderman, M.D | Independent Director | $479,135 |
| Nancy S. Lurker | Independent Director | $476,212 |
| Richard B. Gaynor, M.D | Independent Director | $474,014 |
| Richard F. Pops | Chair of the Board | $0 |
| Shane M. Cooke | Independent Director | $484,751 |
The full Alkermes compensation record
free company briefThis page is one director within Alkermes's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat